The use of cluster and discriminant analysis in the investigations of the role of trace metals in the pathogenesis of Parkinson's disease

Journal of Trace Elements in Medicine and Biology

Volumn 24, Issue 2, 2010, Pages 78-88

  Chwiej, Joanna ^a  

^a AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Metals; Multivariate methods; Parkinson's disease; Synchrotron radiation; X ray fluorescence microscopy

Indexed keywords

BARIUM; CALCIUM; COPPER; IRON; NEUROMELANIN; PHOSPHORUS; POTASSIUM; SELENIUM; SULFUR; TRACE METAL; ZINC;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

CLUSTER ANALYSIS; DISCRIMINANT ANALYSIS; HUMANS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; TRACE ELEMENTS; X-RAYS;

EID: 77952887404     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2009.11.002     Document Type: Article

References (63)

1. Samii A, Nutt JG, Ransom BR Parkinson's disease. Lancet 2004, 363:1783-1793.
2. Toulouse A, Sullivan AM Progress in Parkinson's disease - Where do we stand?. Prog Neurobiol 2008, 10.1016/j.pneurobio.2008.05.003.
3. Wientraub D, Comella CL, Horn S Parkinson's disease - Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care 2008, 14:40-48.
4. Spillantini MG Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies. Parkinsonism Relat Disord 1999, 5:157-162.
5. Przedborski S Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat Disord 2005, 11:3-7.
6. Jenner P, Olanow CW Understanding cell death in Parkinson's disease. Ann Neurol 1998, 44:72-84.
7. Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992, 32:82-87.
8. Sayre LM, Perry G, Smith MA Redox metals and neurodegenerative disease. Curr Opin Chem Biol 1999, 3:220-225.
9. Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 2001, 55:125-132.
10. Rossi L, Lombardo MF, Ciriolo MR, Rotilio G Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res 2004, 29:493-504.
11. Bains JS, Shaw CA Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 1997, 25:335-358.
12. Arundine M, Tymianski M Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003, 34:325-337.
13. Bush AI Metals and neuroscience. Curr Opin Chem Biol 2000, 4:184-191.
14. Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002, 64:1037-1048.
15. Cassarino DS, Bennett JP An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Rev 1999, 29:1-25.
16. Emerit J, Edeas M, Bricaire F Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004, 58:39-46.
17. 2+ and neurodegenerative disease. Eur J Pharmacol 2002, 447:177-188.
18. Swerdlow RH.(The neurodegenerative mitochodriopathies. J Alzheimers Dis 2009 [Epub ahead of print].
19. Schapira AH Etiology and pathogenesis of Parkinson's disease. Neurol Clin 2009, 27:583-603.
20. Thompson KJ, Shoham S, Connor JR Iron and neurodegenerative disorders. Brain Res Bull 2001, 55:155-164.
21. Soto C Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003, 4:49-60.
22. Wanker EE Protein aggregation in Huntington's and Parkinson's disease: implications for therapy. Mol Med Today 2000, 6:387-391.
23. Ross CA, Poirier MA Protein aggregation and neurodegenerative disease. Nature Med 2004, 10:10-17.
24. Adams F, Janssens K, Snigirev A J Anal Atom Spectrosc 1998, 13:319-331.
25. Bohic S, Simionovici A, Ortega R, Heymann D, Schroer C, Snigirev A Synchrotron-induced X-ray microfluorescence on single cells. Nucl Instrum Methods B 2001, 181:728-733.
26. Szczerbowska-Boruchowska M, Chwiej J, Lankosz M, Adamek D, Wojcik S, Krygowska-Wajs A, Tomik B, Bohic S, Susini J, Simionovici A, Dumas P, Kastyak M Intraneuronal investigations of organic components and trace elements with the use of synchrotron radiation. X-ray Spectrom 2005, 34:514-520.
27. Fahrni CJ Biological applications of X-ray fluorescence microscopy: exploring the subcellular topography and speciation of transition metals. Curr Opin Chem Biol 2007, 11:121-127.
28. Snigireva I, Snigirev A J Environ Monit 2006, 8:33-42.
29. Janssens KH, Rindby A, Adams F Microscopic X-ray fluorescence analysis 2000, Wiley, Chichester.
30. Snigireva I, Snigirev A X-ray microanalytical techniques based on synchrotron radiation. J Environ Monit 2006, 8:33-42.
31. Lankosz M, Holynska B, Pella PA X-ray Spectrom 1993, 22:54-57.
32. Fahrni CJ Biological applications of X-ray fluorescence microscopy: exploring the subcellular topography and speciation of transition metals. Curr Opin Chem Biol 2007, 11(121):127.
33. Tomik B, Chwiej J, Szczerbowska-Boruchowska M, Lankosz M, Wojcik S, Adamek D, Falkenberg G, Bohic S, Simionovici A, Stegowski Z, Szczudlik A Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis. Neurochem Res 2006, 31:321-331.
34. Ide-Ektessabi A, Rabionet M The role of trace metallic elements in neurodegenerative disorders: quantitative analysis using XRF and XANES spectroscopy. Anal Sci 2005, 21:885-892.
35. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with Β-amyloid deposits in Alzheimer's disease. J Struct Biol 2006, 155:30-37.
36. Ralle M, Blackburn NJ, Lutsenko S. Using XAS and SXRF to study copper in Wilson disease at the molecular and tissue level. AIP Conference Proceedings 882, 13th International Conference on X-ray absorption fine structure, 2006. p. 328-30.
37. Osterode W, Falkenberg G, Hoftberger R, Wrba F Iron, copper, zinc and bromine mapping in cirrhotic liver slices from patients with hemochromatosis studied by microscopic synchrotron radiation X-ray fluorescence analysis in continuous scanning mode. Spectrochim Acta B 2007, 62:682-688.
38. Farquharson MJ, Geraki K, Falkenberg G, Leek R, Harris A. The localisation and micro-mapping of copper and other trace elements in breast tumours using a synchrotron micro-XRF system. Appl Rad Isotopes 2007;65:183-8.
39. Ortega R, Fayard B, Salome M, Deves G, Susini J. Chromium oxidation state imaging in mammalian cells exposed in vitro to soluble or particulate chromate compounds. Chem Res Toxicol 2005, 18:1512-1519.
40. Zhang CX, Lippard SJ. New metal complexes as potential therapeutics. Curr Op Chem Biol 2003;7:481-9.
41. 2-oligonucleotide nanocomposites. Nat Mater 2003, 2:343-346.
42. McRae R, Lai B, Vogt S, Fahrni CJ Correlative microXRF and optical immunofluorescence microscopy of adherent cells labelled with ultrasmall gold particles. J Struct Biol 2006, 155:22-29.
43. Rechner AC Methods of multivariate analysis 2002, John Wiley & Sons, Chichester.
44. Abe K, Asai Y, Matsuo Y, Nomura T, Sato S, Inoue S, Mizukura I, Sakosa S Classifying lower limb dynamics in Parkinson's disease. Brain Res Bull 2003, 61:219-226.
45. White SG, McNair PJ Abdominal and erector spinae muscle activity during gait: the use of cluster analysis to identify patterns of activity. Clin Biomech 2002, 17:177-184.
46. Post B, Speelman JD, de Haan RJ Clinical heterogeneity in newly diagnosed Parkinson's disease. J Neurol 2008, 255:716-722.
47. Vekemans B, Vincze L, Brenker FE, Adams F Processing of three-dimensional microscopic X-ray fluorescence data. J Anal Atom Spectrom 2004, 19:1302-1308.
48. De Samber B, Evens R, De Samber B, Evens R, De Schamphelaere K, Silversmit G, Masschaele B, Schoonjans T, Vekemans B, Janssen CR, Van Hoorebeke L, Szalóki I, Vanhaecke F, Falkenberg G, Vincze L. A combination of synchrotron and laboratory X-ray techniques for studying tissue-specific trace level metal distributions in Daphnia magna. J Anal Atom Spectrom 2008, 23:829-839.
49. Cariati F, Fermo P, Gilardoni S, Galli A, Milazzo M A new approach for archaeological ceramics analysis using total reflection X-ray fluorescence spectrometry. Spectrochim Acta B 2003, 58:177-184.
50. Gurusamy KS, Farquharson MJ, Craig C, Davidson BR An evaluation study of trace element content in colorectal liver metastases and surrounding normal livers by X-ray fluorescence. Biometals 2008, 21:373-378.
51. Da Silva MP, OLAD Zucchi, Ribeiro-Silva A, Poletti ME Discriminant analysis of trace elements in normal, benign and malignant breast tissues measured by total reflection X-ray fluorescence. Spectrochim Acta B 2009, 64:587-592.
52. Theodorakou C, Farquharson MJ The classification of secondary colorectal liver cancer in human biopsy samples using angular dispersive x-ray diffraction and multivariate analysis. Phys Med Biol 2009, 54:4945-4957.
53. Kettenring JR The practice of cluster analysis. J Classif 2006, 23:3-30.
54. Krygowska-Wajs A, Adamek D, Szczudlik A, Kałuża An attempt at evaluating borderline conditions of Parkinson's disease and its preclinical stage on the basis of clinical and morphological correlation. Folia Neuropath 2002, 40:57-66.
55. Falkenberg G, Clauss O, Tschentscher T X-ray optics for the microfocus beamline L Hasylab Annual Report, 2001, http://www-hasylab.desy.de/science/annual_reports/2001_report/index.html.
56. Website of beamline ID 22: http://www.esrf.fr/UsersAndScience/Experiments/Imaging/ID22/.
57. Vekemans B, Vincze L, Somogyi A, Drakopoulos M, Kempenaers L, Simionovici A, Adams F Quantitative X-ray fluorescence analysis at the ESRF ID18F microprobe. Nucl Instrum Methods B 2003, 199:396-401.
58. Currie LA Limits of qualitative detection and quantitative determination. Anal Chem 1968, 40:586-593.
59. Alimonti A, Bocca B, Pino A, Ruggieri F, Forte G, Sancesario G Elemental profile of cerebrospinal fluid in patients with Parkinson's disase. J Trace Elem Med Biol 2007, 21:234-241.
60. Forte G, Alimonti A, Violante N, Di Gregorio M, Senofonte O, Petrucci F, Sancesario G, Bocca B Calcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson's disease. J Trace Elem Med Biol 2005, 19:195-201.
61. Bocca B, Alimonti A, Senofonte O, Pino A, Violante N, Petrucci F, Sancesario G, Forte G Metal changes in CSF and peripheral compartments of parkinsonian patients. J Neurol Sci 2006, 248:23-30.
62. Forte G, Bocca B, Senofonte O, Petrucci F, Brusa L, Stanzione P, Zannino S, Violante N, Alimonti A, Sancesario G Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J Neural Transm 2004, 111:1031-1040.
63. Pande MB, Nagabhushan P, Hegde ML, Rao TS, Rao KS An algorithmic approach to understand trace elemental homeostasis in serum samples of Parkinson disease. Comput Biol Med 2005, 35:475-493.